Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Electron Kebebew

Showing results (311-320 of 378) with videos related to

Pageof 38
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2018
Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>Shilpa Thakur, Brianna Daley, Kelli Gaskins, et al.
The Journal of Surgical Research|May 31, 2019
MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and ParagangliomasSamantha M Ruff, Reed I Ayabe, Parisa Malekzadeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid CancerAmit Mehta, Lisa Zhang, Myriem Boufraqech, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2008
Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?Rasa Zarnegar, Alan I Bloom, James Lee, et al.
Surgery|December 8, 2010
A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsyAarti Mathur, Julie Weng, Willieford Moses, et al.
Surgery|November 8, 2017
Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cureMustapha El Lakis, Pavel Nockel, Bin Guan, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2012
DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumorsNesrin S Rechache, Yonghong Wang, Holly S Stevenson, et al.
Cancer Letters|November 28, 2025
Corrigendum to "Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis" [Cancer Letters 633 (2025) 217990]Chandrayee Ghosh, Tejinder Pal Khaket, Viswanath Gunda, et al.
American Journal of Human Genetics|October 18, 2016
GCM2-Activating Mutations in Familial Isolated HyperparathyroidismBin Guan, James M Welch, Julie C Sapp, et al.
Journal of the National Cancer Institute|February 27, 2018
Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine TumorsNaris Nilubol, ZiQiang Yuan, Giulio F Paciotti, et al.
Pageof 38

Showing results (311-320 of 378) with videos related to

Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2018
Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>Shilpa Thakur, Brianna Daley, Kelli Gaskins, et al.
The Journal of Surgical Research|May 31, 2019
MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and ParagangliomasSamantha M Ruff, Reed I Ayabe, Parisa Malekzadeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid CancerAmit Mehta, Lisa Zhang, Myriem Boufraqech, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2008
Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?Rasa Zarnegar, Alan I Bloom, James Lee, et al.
Surgery|December 8, 2010
A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsyAarti Mathur, Julie Weng, Willieford Moses, et al.
Surgery|November 8, 2017
Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cureMustapha El Lakis, Pavel Nockel, Bin Guan, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2012
DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumorsNesrin S Rechache, Yonghong Wang, Holly S Stevenson, et al.
Cancer Letters|November 28, 2025
Corrigendum to "Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis" [Cancer Letters 633 (2025) 217990]Chandrayee Ghosh, Tejinder Pal Khaket, Viswanath Gunda, et al.
American Journal of Human Genetics|October 18, 2016
GCM2-Activating Mutations in Familial Isolated HyperparathyroidismBin Guan, James M Welch, Julie C Sapp, et al.
Journal of the National Cancer Institute|February 27, 2018
Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine TumorsNaris Nilubol, ZiQiang Yuan, Giulio F Paciotti, et al.
Pageof 38